Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06570629

Addressing Unintentional Leakage When Using Nasal CPAP - Study B

Mechanisms of Weight Gain During CPAP Treatment in Patients With Obstructive Sleep Apnea

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Oral unintentional leak is a common side effect of continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA) treatment. Management of oral unintentional leakage has not been standardized and the effectiveness of potential approaches have not been studied in controlled studies. Higher levels of CPAP are associated with higher leak. In the present study, a sequential approach to control excessive unintentional leak will be tested. In study A, the reduction of therapeutic CPAP level will be tested. In study B, oronasal CPAP will be compared to nasal CPAP with a chinstrap.

Detailed description

Study B will consist of a controlled crossover trial to compare unintentional leak during the use of an oronasal mask versus a nasal mask with a chinstrap, among subjects who remain with excessive leak at the end of study A. The order of interventions will be randomized. One of the groups will initially use an oronasal mask for 10 days. A washout period of 7 days under nasal CPAP will follow. After washout, subjects will continue using a nasal mask and will be asked to use a chinstrap for another 10 days. In the other group, the order of interventions will be the opposite.

Conditions

Interventions

TypeNameDescription
DEVICEOronasal CPAPIn this crossover trial, subjects will use CPAP with either an oronasal mask or a. nasal mask with a chinstrap for 7 days. The order of each intervention will be randomized.
DEVICENasal CPAP plus ChinstrapIn this crossover trial, subjects will use CPAP with either an oronasal mask or a. nasal mask with a chinstrap for 7 days. The order of each intervention will be randomized.

Timeline

Start date
2025-04-30
Primary completion
2025-12-31
Completion
2028-12-31
First posted
2024-08-26
Last updated
2025-04-30

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT06570629. Inclusion in this directory is not an endorsement.